(7) In 2018, an estimated 21,200,000 people 
aged 12 or older in the United States needed sub-
stance use treatment. 
(8) According to the Substance Abuse and Men-
tal Health Services Administration, COVID–19 will 
certainly contribute to growth in the numbers re-
ferred to in the preceding paragraphs. Individuals 
across the United States will struggle with increases 
in depression, anxiety, trauma, and grief. There is 
also anticipated increase in substance misuse in the 
United States as lives are impacted for individuals 
and families. 
SEC. 3. GRANT PROGRAM ON HARMS OF DRUG MISUSE. 
(a) IN GENERAL.—The Assistant Secretary for Men-
tal Health and Substance Use (referred to in this section 
as the ‘‘Assistant Secretary’’), in consultation with the Di-
rector of the Centers for Disease Control and Prevention, 
shall award grants to States, political subdivisions of 
States, Tribes, Tribal organizations, and community-based 
entities to support the delivery of overdose prevention, sy-
ringe services programs, and other harm reduction serv-
ices that address the harms of drug misuse during the 
COVID–19 pandemic, including by— 
(1) preventing and controlling the spread of in-
fectious diseases, such as HIV/AIDS and viral hepa-
VerDate Sep 11 2014 
18:09 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H706.IH
H706
pamtmann on DSKBC07HB2PROD with BILLS
titis, and the consequences of such diseases for indi-
viduals with substance use disorder; 
(2) distributing opioid antagonists, such as 
naloxone, to individuals at risk of overdose; 
(3) connecting individuals at risk for, or with, 
a substance use disorder to overdose education, 
counseling, and health education; and 
(4) encouraging such individuals to take steps 
to reduce the negative personal and public health 
impacts of substance use or misuse during the emer-
gency period. 
(b) CONSIDERATIONS.—In awarding grants under 
this section, the Assistant Secretary shall prioritize grants 
to applicants that are— 
(1) culturally specific organizations, Tribal be-
havioral health and substance use disorder providers, 
or organizations that are intentional about serving 
populations where COVID–19 has had the most im-
pact; or 
(2) proposing to serve areas with— 
(A) a higher proportion of the population 
who meet criteria for dependence on, or abuse 
of, illicit drugs; 
(B) a higher drug overdose death rate; 
VerDate Sep 11 2014 
18:09 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6201
E:\BILLS\H706.IH
H706
pamtmann on DSKBC07HB2PROD with BILLS
(C) a greater telemedicine infrastructure 
need; and 
(D) a greater behavioral health and sub-
stance use disorder workforce need. 
(c) USE OF GRANT AWARDS.—A recipient of a grant 
under this section may use such grant funds for the fol-
lowing purposes: 
(1) Adapt, maintain, and expand essential serv-
ices provided by harm reduction service organiza-
tions to address the risks of COVID–19, drug over-
dose, and contraction of infectious disease. 
(2) Maintain or hire staff. 
(3) Support program operational costs, includ-
ing staff, rent, and vehicle purchase or maintenance. 
(4) Program supplies. 
(5) Hygiene and personal protective equipment 
for both staff and program participants. 
(6) Support and case management services. 
(d) DEFINITION.—In this section, the term ‘‘emer-
gency period’’ has the meaning given to such term in sec-
tion 1135(g)(1)(B) of the Social Security Act (42 U.S.C. 
1320b–5(g)(1)(B)). 
(e) AUTHORIZATION OF APPROPRIATIONS.—To carry 
out this section, there is authorized to be appropriated 
VerDate Sep 11 2014 
18:09 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00005
Fmt 6652
Sfmt 6201
E:\BILLS\H706.IH
H706
pamtmann on DSKBC07HB2PROD with BILLS
$50,000,000 for fiscal year 2021, to remain available until 
expended. 
Æ 
VerDate Sep 11 2014 
18:09 Feb 23, 2021
Jkt 019200
PO 00000
Frm 00006
Fmt 6652
Sfmt 6301
E:\BILLS\H706.IH
H706
pamtmann on DSKBC07HB2PROD with BILLS